Chemical Market Reporter - RAMIPRIL.
King Pharmaceuticals Inc. has submitted a supplemental new drug application to FDA for the approval of new and unique indications for Altace (ramipril), an angiotensin converting enzyme inhibitor currently indicated for …
Related Results
Sandoz launches ramiprilCutaneous vasculitis secondary to ramiprilRamipril cuts diabetes riskRamipril-associated hepatotoxicityRamipril in rheumatoid arthritis
Read the rest of this article with a Free Trial at HighBeam Research.
